{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:16:04Z","timestamp":1761218164568,"version":"3.44.0"},"reference-count":18,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,5,27]]},"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>Compared with the general population, rates of pheochromocytoma are higher in neurofibromatosis type 1 (NF1) patients. However, pheochromocytoma testing is often plagued by false positive results. Here we present a patient with NF1, elevated urinary metanephrine levels, and an indeterminate adrenal nodule. Clonidine suppression testing aided diagnosis and led to definitive surgical treatment that confirmed a pheochromocytoma. Pheochromocytoma screening and clonidine suppression testing can both aid in the evaluation for catecholamine-secreting tumours.<\/jats:p>","DOI":"10.1136\/bcr-2018-228263","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T05:05:17Z","timestamp":1561525517000},"page":"e228263","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Clonidine suppression testing for pheochromocytoma in neurofibromatosis type 1"],"prefix":"10.1136","volume":"12","author":[{"given":"WingYee","family":"Wan","sequence":"first","affiliation":[{"name":"Internal Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bichle","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Internal Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sky","family":"Graybill","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Brooke Army Medical Center, Fort Sam Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Kim","sequence":"additional","affiliation":[{"name":"Internal Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"2025082710540089000_12.6.e228263.1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.14740\/jem308w","article-title":"Neurofibromatosis type 1 with a pheochromocytoma: A rare presentation of von recklinghausen disease","volume":"5","author":"Zafar","year":"2015","journal-title":"J Endocrinol Metab"},{"key":"2025082710540089000_12.6.e228263.2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3889\/oamjms.2015.130","article-title":"Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension","volume":"3","author":"Petrovska","year":"2015","journal-title":"Open Access Maced J Med Sci"},{"key":"2025082710540089000_12.6.e228263.3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3892\/ol.2016.4670","article-title":"Neurofibromatosis type 1 associated with pheochromocytoma and gastrointestinal stromal tumors: A case report and literature review","volume":"12","author":"Pan","year":"2016","journal-title":"Oncol Lett"},{"key":"2025082710540089000_12.6.e228263.4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/2230-8210.109670","article-title":"Neurofibromatosis type 1, pheochromocytoma with primary hyperparathyroidism: A rare association","volume":"17","author":"Behera","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"2025082710540089000_12.6.e228263.5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/2230-8210.86988","article-title":"Neurofibromatosis 1 with pheochromocytoma","volume":"15","author":"Hari Kumar","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"2025082710540089000_12.6.e228263.6","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-8-14"},{"key":"2025082710540089000_12.6.e228263.7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0976-3147.91987","article-title":"Type 1 neurofibromatosis and pheochromocytoma: Focus on hypertension","volume":"3","author":"Rocchietti March","year":"2012","journal-title":"J Neurosci Rural Pract"},{"key":"2025082710540089000_12.6.e228263.8","first-page":"2050313X1774101","article-title":"The importance of pheochromocytoma case detection in patients with neurofibromatosis type 1: A case report and review of literature","volume":"5","author":"Tate","year":"2017","journal-title":"SAGE Open Med Case Rep"},{"key":"2025082710540089000_12.6.e228263.9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40842-018-0065-4","article-title":"Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening","volume":"4","author":"Petr","year":"2018","journal-title":"Clin Diabetes Endocrinol"},{"key":"2025082710540089000_12.6.e228263.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498"},{"key":"2025082710540089000_12.6.e228263.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-030005"},{"key":"2025082710540089000_12.6.e228263.12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0233"},{"key":"2025082710540089000_12.6.e228263.13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.ackd.2014.11.002","article-title":"Catecholamine excess: pseudopheochromocytoma and beyond","volume":"22","author":"Garcha","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"2025082710540089000_12.6.e228263.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02805.x"},{"key":"2025082710540089000_12.6.e228263.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030720"},{"key":"2025082710540089000_12.6.e228263.16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/jhh.2010.78","article-title":"Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma","volume":"25","author":"McHenry","year":"2011","journal-title":"J Hum Hypertens"},{"key":"2025082710540089000_12.6.e228263.17","doi-asserted-by":"crossref","unstructured":"Ergin A , Kennedy A , Gupta M , et al . The cleveland clinic manual of dynamic endocrine testing. Springer International Publishing 2015.","DOI":"10.1007\/978-3-319-13048-4"},{"key":"2025082710540089000_12.6.e228263.18","first-page":"1138","article-title":"The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma","volume":"35","author":"Mozley","year":"1994","journal-title":"J Nucl Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-228263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:54:11Z","timestamp":1756317251000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-228263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,25]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/bcr-2018-228263"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-228263","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}